HMGB1 and hepatocellular carcinoma: It has been reported that the serum HMGB1 levels in patients with HCC were significantly higher than those with single chronic hepatitis and healthy controls (Tang et al., 2010), indicating that HMGB1 can be an important and reliable serous marker of chronic liver diseases and used to predict the processes in HCC patients.